A. Achaiah, L. Fox, Melissa Zhao, R. Mckevitt, N. Toosi, W. Storrar
{"title":"Managing Sarcoidosis in a District General Hospital in Southern England: An 8 year retrospective analysis of treatment","authors":"A. Achaiah, L. Fox, Melissa Zhao, R. Mckevitt, N. Toosi, W. Storrar","doi":"10.1183/13993003.congress-2019.pa1387","DOIUrl":"https://doi.org/10.1183/13993003.congress-2019.pa1387","url":null,"abstract":"","PeriodicalId":439129,"journal":{"name":"Sarcoidosis and other granulomatous ILD/DPLD","volume":"20 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124735543","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Laura Köcher, M. Rossides, K. Remaeus, J. Grunewald, A. Eklund, S. Kullberg, E. Arkema
{"title":"Maternal and fetal outcomes in sarcoidosis pregnancy: a Swedish population-based cohort study","authors":"Laura Köcher, M. Rossides, K. Remaeus, J. Grunewald, A. Eklund, S. Kullberg, E. Arkema","doi":"10.1183/13993003.congress-2019.oa5156","DOIUrl":"https://doi.org/10.1183/13993003.congress-2019.oa5156","url":null,"abstract":"Background: It is unclear whether sarcoidosis, a multisystem inflammatory disease, is associated with adverse pregnancy outcomes. Aim: To assess the risk of adverse maternal and fetal outcomes in sarcoidosis pregnancies. Methods: Using a population-based cohort study design and Swedish national registers (2002-2013), we identified 764 singleton pregnancies (258 first pregnancies) in the Medical Birth Register with at least one maternal ICD-coded sarcoidosis visit prior to pregnancy in the National Patient Register. Modified Poisson regression models adjusted for age at delivery, calendar year and educational level estimated relative risks (RR) of adverse maternal and fetal outcomes in sarcoidosis pregnancies compared to the general population. Some models were additionally adjusted for body mass index, smoking and comorbidity. Results: The prevalence of pre-existing diabetes and hypertension was higher in mothers with sarcoidosis than those without sarcoidosis. Mothers with sarcoidosis had slightly elevated risks for caesarean section (RR 1.1; 95%CI 1.0-1.3) and induced labour (RR 1.2; 95%CI 1.1-1.5). Although rare (occurring in Conclusions: Sarcoidosis is associated with increased risks for some adverse pregnancy outcomes.","PeriodicalId":439129,"journal":{"name":"Sarcoidosis and other granulomatous ILD/DPLD","volume":"33 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130637500","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Can High Frequency Transthoracic Sonography Play a Competition Role with High Resolution Computed Tomography in Assessment of Dyspnea?","authors":"G. Agmy, M. Adam, Manal Ahmed, M. Azmy","doi":"10.1183/13993003.congress-2019.pa1383","DOIUrl":"https://doi.org/10.1183/13993003.congress-2019.pa1383","url":null,"abstract":"The aim of the study was to assess the significance and diagnostic concert of pleural line aberrations and B-lines detected by high-resolution transthoracic sonography (TS) in contradiction of the high resolution computed tomography (HRCT) findings. The pleural lines and accompanying B-line were assessed using a linear transducer. The TS findings were assessed against the corresponding HRCT findings in the same location, which were considered to be the gold standard. Among 320 patients, pleural line changes were detected in 240 patients (75%) on TS. The characteristic variations of the pleural line were categorized into four types: slightly rough pleural line with confluent B-lines on TS corresponded with HRCT findings of ground-glass opacity; irregular and interrupted pleural line with confluent B-lines corresponded with parenchymal infiltration; fringed pleural line with confluent B-lines corresponded with superimposed ground-glass and irregular reticular opacities; and fringed pleural line with scattered B-lines corresponded with irregularly thickened interlobular septa. Wavy pleural line indicated subpleural emphysema. The coexistence of more than one abnormal pleural line was also found in in 96 cases (30%). In conclusion, High-frequency TS may help in the early assessment of lung pathology by its ability to recognize pleural line anomalies and B-lines that are shown to be associated with CT changes, which could add diagnostic value in the emergency assessment of dyspneic patients.","PeriodicalId":439129,"journal":{"name":"Sarcoidosis and other granulomatous ILD/DPLD","volume":"66 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134088568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Comparative analysis of the efficacy of glucocorticosteroids and antimetabolite drugs in treatment of patients with pulmonary sarcoidosis","authors":"I. Merenkova, Y. Dziublyk, G. Gumeniuk","doi":"10.1183/13993003.congress-2019.pa1945","DOIUrl":"https://doi.org/10.1183/13993003.congress-2019.pa1945","url":null,"abstract":"Glucocorticosteroids (GCS) remain the first line drugs in management of pulmonary sarcoidosis with its efficacy proven in multiple clinical trials. The initial monotherapy with antimetabolite drugs is only used in patients with contraindications to GCS. At this point, as it is widely accepted by majority of authors, a methotrexate is a drug of choice. Aim: to compare the efficacy of GCS and antimetabolite drugs in patients with newly diagnosed pulmonary sarcoidosis. Methods: There were examined 94 patients, which received treatment with methylprednisolone. The stage II of sarcoidosis was revealed in 88 patients, stage III – in 6 patients. Methylprednisolone was administered in dose 0,4 mg/kg of body weight during 4 weeks with subsequent tapering of dose by 0,2 mg/kg at the end of third month (Visit 2). In 33 patients with stage II pulmonary sarcoidosis we prescribed methotrexate 10 mg once per week. This therapy was used as initial because of the revealed contraindications for the use of GCS. General clinical examination, chest CT scan and spirometry were performed. The examination was conducted before the start of the therapy, in three months (Visit 2) and in 6 moths (Visit 3) of treatment. Results: The results are presented in the table. The regression of the disease was registered in 80,9 % of patients in methylprednisolone arm and in 78,8 % in methotrexate arm. Conclusion: The methotrexate monotherapy is non-inferior to the methylprednisolone in terms of the efficacy in patients with newly diagnosed pulmonary sarcoidosis.","PeriodicalId":439129,"journal":{"name":"Sarcoidosis and other granulomatous ILD/DPLD","volume":"33 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114344507","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
G. Okumus, Z. Bingol, Merve Sarisoy, T. Cagatay, E. Kıyan, Z. Kılıçaslan
{"title":"The role of salivary gland biopsy in the diagnosis of sarcoidosis","authors":"G. Okumus, Z. Bingol, Merve Sarisoy, T. Cagatay, E. Kıyan, Z. Kılıçaslan","doi":"10.1183/13993003.congress-2019.pa1946","DOIUrl":"https://doi.org/10.1183/13993003.congress-2019.pa1946","url":null,"abstract":"Introduction: Minor salivary gland biopsy is used as a minimally invasive method in the diagnosis of sarcoidosis. To date, a few studies have shown that minor salivary gland biopsy is an diagnostic tool in differentiating sarcoidosis from tuberculosis. In this study we evaluated the diagnostic yield of minor salivary gland biopsy in patients with sarcoidosis. Material and methods: The study included patients with sarcoidosis who were diagnosed during the last 10 years in Pulmonary Department of Istanbul Medical Faculty. Baseline diagnostic tests, histopathological results and clinical findings were recorded. Results: Totally, 354 patients (270 female, 84 male, mean age: 46.48) with sarcoidosis were analyzed. Radiologically, 7.3% was stage 0, 46.6% was stage I, 33% was stage II, 9% was stage III, and 3.9% was stage IV. Respiratory functions were normal in 70%, diffusion capacity was normal in 66% and 18.8% had obstructive pattern, 10.9% had restrictive pattern in spirometry. The most common extrapulmonary involvement was skin (%22.8) and eye (%16.9). Minor salivary gland biopsy was performed in 215 cases and 49.3% of them had findings compatible with sarcoidosis. In 13.8% of the cases, the diagnosis was based on only minor salivary gland biopsy and clinical-radiological findings. Conclusion: In our study, salivary gland biopsy was diagnostic in half of the cases, and in 13.8% of the cases was diagnosed without any other invasive procedure. Therefore, it can be used as a priority biopsy method in patients with clinical and radiological suspicion of sarcoidosis.","PeriodicalId":439129,"journal":{"name":"Sarcoidosis and other granulomatous ILD/DPLD","volume":"48 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127230285","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
N. Basantsova, Y. Zinchenko, V. Shapkina, A. Dori, A. Starshinova, P. Yablonskiy
{"title":"Clinical manifestation of small fiber neuropathy in patients with sarcoidosis and tuberculosis","authors":"N. Basantsova, Y. Zinchenko, V. Shapkina, A. Dori, A. Starshinova, P. Yablonskiy","doi":"10.1183/13993003.congress-2019.pa1953","DOIUrl":"https://doi.org/10.1183/13993003.congress-2019.pa1953","url":null,"abstract":"Introduction: Patients with sarcoidosis (SC) and tuberculosis (TB) can develop a small fiber neuropathy (SFN), that is worsening the prognosis. Aim: To investigate the clinical manifestation of SFN in patients with SC and TB. Materials and Methods: In 2018-19, patients with histologically verified pulmonary SC (17 men, 5 women, aged 33.4±8.5 years), 16 patients with pulmonary TB in the pre-treatment period (9 men, 10 women, aged 36.6±9.3 years) and 73 healthy subjects (HS, 43 men, 30 women, aged 53,5±13,92 years) were included. A complete neurological investigation was performed. The questionnaire “Small fiber neuropathy screening list in sarcoidosis” (SFN-SL) was used as a validated test for the SFN evaluation. Statistical analysis was performed with Statistica 8.0 (StatSoft, Inc., USA). Differences were significant at p Results and Discussion: The average score for SFN-SL scale in patients with SC was 2.0 (0;7.3) points, 15/67.9% of them described symptoms of SFN. The majority of patients with TB had no SFN complains (average score 0.2 (0;0.4) points), only 4/21% had typical neurologic symptoms. HS had 0 (0;0) points, 1/1.4% had SFN complaints. Patients with SC had higher SFN scores in comparison with TB (p=0.001) and HS (p Conclusion: In patients with SC the manifestation of neuropathy of small fibers was described more frequent, that requires verification and prescription of therapy. TB patients had more frequent SFN symptoms than HS, that may require immunological studies.","PeriodicalId":439129,"journal":{"name":"Sarcoidosis and other granulomatous ILD/DPLD","volume":"10 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125523206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. Vizel’, I. Vizel’, G. Shakirova, Pavel Kolesnilkov
{"title":"Splenomegalia in patients with pulmonary sarcoidosis","authors":"A. Vizel’, I. Vizel’, G. Shakirova, Pavel Kolesnilkov","doi":"10.1183/13993003.congress-2019.pa1379","DOIUrl":"https://doi.org/10.1183/13993003.congress-2019.pa1379","url":null,"abstract":"Recombinant tissue plasminogen activator (rtPA) is currently the only approved thrombolytic agent for treating acute ischaemic stroke that is widely used in clinical practice. However, it may cause haemorrhage and hypersensitivity reactions. Orolingual angioedema is an infrequent, usually mild but potentially life threatening, hypersensitivity reaction to rtPA. Our understanding of the basic biology of angioedema has increased in recent years. There is growing evidence that rtPA-induced orolingual angioedema is driven mainly by bradykinin generation rather than it being an anaphylactic response. Monitoring is important because orolingual angioedema may evolve and compromise airways and a small number do have angioedema as part of systemic anaphylaxis. There are no published guidelines for treating rtPA-induced orolingual angioedema, although some evidence suggests that those refractory to standard antianaphylactic agents may resolve with bradykinin B2 receptor antagonists. It is important that responses to orolingual angioedema are proportionate and that patients are closely monitored.","PeriodicalId":439129,"journal":{"name":"Sarcoidosis and other granulomatous ILD/DPLD","volume":"33 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132161737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
S. Stanel, A. Papadopoulos, C. Leonard, N. Chaudhuri, P. Rivera-Ortega
{"title":"Association of demographic, laboratory and clinical parameters with HRCT-chest findings in patients with sarcoidosis","authors":"S. Stanel, A. Papadopoulos, C. Leonard, N. Chaudhuri, P. Rivera-Ortega","doi":"10.1183/13993003.congress-2019.pa1385","DOIUrl":"https://doi.org/10.1183/13993003.congress-2019.pa1385","url":null,"abstract":"","PeriodicalId":439129,"journal":{"name":"Sarcoidosis and other granulomatous ILD/DPLD","volume":"191 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133396070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
F. Cinetto, R. Scarpa, Raffaella Neri, Sabrina Gianese, C. Agostini
{"title":"Granulomatous-Lymphocytic interstitial lung disease (GLILD) in CVID: A case-control single center retrospective study","authors":"F. Cinetto, R. Scarpa, Raffaella Neri, Sabrina Gianese, C. Agostini","doi":"10.1183/13993003.congress-2019.pa1955","DOIUrl":"https://doi.org/10.1183/13993003.congress-2019.pa1955","url":null,"abstract":"8 to 22% of patients with Common Variable Immunodeficiency (CVID) develop GLILD, associated with bad prognosis. GLILD is characterized by diffuse radiological abnormalities and/or histologic evidence of granulomatous inflammation with lymphoproliferative changes. Proper management is unknown. In this retrospective single-centre study, chest HRCT scans of 34 CVID patients were blind-reviewed by 2 radiologists. 15/34 patients presented HRCT findings consistent with GLILD. Different parameters were compared between patients with HRCT patterns consistent with GLILD and those without GLILD features. The mean percentage of circulating B lymphocytes was lower in GLILD-patients. GLILD-patients presented a reduced percentage of switched-memory B cells and a higher percentage of activated B cells. IgG, IgA and IgM levels at diagnosis were lower in GLILD patients, requiring higher levels of IgG replacement. Splenomegaly was found in 53.3% of GLILD patients and in 15% of controls. 3/15 GLILD-patients underwent splenectomy due to autoimmune cytopenias. None of the controls had autoimmune cytopenia. 14/15 GLILD-patients had FEV1 and FVC > 70%. DLCO was reduced (","PeriodicalId":439129,"journal":{"name":"Sarcoidosis and other granulomatous ILD/DPLD","volume":"22 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114739809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. Abedini, A. Kiani, Ali Safavi Naeini, Kimia Taghavi, N. Bandegani, M. Kazempour-Dizaji
{"title":"Sinonasal sarcoidosis in Iran","authors":"A. Abedini, A. Kiani, Ali Safavi Naeini, Kimia Taghavi, N. Bandegani, M. Kazempour-Dizaji","doi":"10.1183/13993003.congress-2019.pa1391","DOIUrl":"https://doi.org/10.1183/13993003.congress-2019.pa1391","url":null,"abstract":"Introduction: Sarcoidosis is a granulomatous disease, and about 1-15% of patients with sarcoidosis show sinonasal involvements. Since, sinonasal involvements are similar to non-sarcoid rhinosinusitis and infectious rhinosinusitis and allergies, accurate diagnosis of Sinonasal Sarcoidosis (SNS) patients is mandatory to minimize unnecessary antibiotics and surgical treatments in sarcoidosis patients. This was the first study in Iran, to evaluate the SNS cases and their clinical presentations. Methods: In this cross-sectional study, eighty-eight biopsy proven sarcoidosis patients, with head and neck complaints, were included. All patients underwent the Computed Tomography of Para-nasal Sinuses (CT PNS) and a biopsy sampling through the rhinoscopy. Data were analyzed by Statistical Package for Social Sciences (SPSS) and differences between two groups were obtained with consideration of p-value of Results: CT PNS confirmed sinonasal disorders in 32 patients. 18 of 32 SNS patients had pulmonary involvements (56.25%). Rhinoscopy demonstrated nasal crusting in four patients (14.3%), septal perforation in three patients (8.6%), mucosal hypertrophy in nine patients (28.6%), synechia in two patients (5.7%), middle turbinate hypertrophy in four patients (11.4%) and submucosal nodule in ten patients (31.4%). Conclusions: Sinonasal involvement in patients with sarcoidosis may not be correctly detected only based on the symptoms. Hence, we suggest CT scan as the first diagnostic step in patients suspected to sinonasal involvements. In the case of observing an abnormal CT pattern and an increase in the level of ACE, further histopathologic examinations on the sinonasal biopsies is recommended.","PeriodicalId":439129,"journal":{"name":"Sarcoidosis and other granulomatous ILD/DPLD","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2019-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130386318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}